期刊文献+

耐多药肺结核133例外科治疗效果探讨 被引量:22

Surgical treatment of 133 cases of multi-drug-resistant pulmonary tuberculosis
原文传递
导出
摘要 目的探讨肺切除术在耐多药肺结核治疗中的重要性。方法回顾性分析北京胸科医院1980年1月至2007年12月行肺切除术治疗的133例耐多药肺结核患者的临床资料。手术方式包括全肺切除(45例)、肺叶切除(73例,包括支气管袖式成型5例)、胸膜全肺切除(13例)、肺段切除(1例)、楔形切除(1例),术前均进行6个月以上的抗结核治疗,术后继续抗结核治疗6~18个月。结果133例中围手术期死于呼吸衰竭的2例,内出血1例,死亡3例(2.3%);并发症发生率为17.3%(23/133),其中支气管残端瘘9例。术后随访6个月至15年,平均52个月,用药时问为6~18个月,痰MTB阴转率为90.2%(101/112)。结论对持续痰MTB阳性,且病灶局限或痰MTB转阴、病灶局限,继续抗结核治疗3个月以上病变无好转或加重的耐多药肺结核患者,应积极采取手术治疗,肺切除术能有效提高患者的治愈率。应用吻合器缝合残端可明显降低瘘的发生率。 Objective To evaluate the clinical significance of pulmonary resection for multi-drugresistant pulmonary tuberculosis. Methods The clinical data were retrospectively reviewed for patients with multi-drug-resistant pulmonary tuberculosis for which surgical resection of the lung was undertaken. Results From January 1980 to December 2007, 1188 patients with pulmonary tuberculosis, including 133 muhi-drug resistant cases, underwent pulmonary resection in Beijing Chest Hospital. Surgical procedures included pneumonectomy in 45, pulmonary lobectomy in 73 (including sleeve resection of the bronchus in 5 ) , pleuropneumonectomy in 13, segment resection in 1, and wedge resection in 1 cases. Preoperative and postoperative antituberculosis chemotherapy was given for no less than 6 months and 6 to 18 months, respectively. Two cases died of perioperative respiratory failure, and 1 died of internal bleeding, the mortality rate being 2. 3% ( 3/133 ) . The incidence of postoperative complications was 17. 3% (23/133), including 9 cases with stump fistula of bronchus. Follow-up lasted for 6 months to 15 years (average 52 months), and medical treatment lasted for 6 - 18 months. After follow-up, the sputum negative conversion rate was 90.2% (101/112). Conclusions Pulmonary resection is an effective approach to multi-drug resistant pulmonary tuberculosis with long-term sputum positivity of limited local lesions, or negative sputum of local lesions but failure to antitubereulosis chemotherapy for at least 3 months.
作者 于大平 傅瑜
出处 《中华结核和呼吸杂志》 CAS CSCD 北大核心 2009年第6期450-453,共4页 Chinese Journal of Tuberculosis and Respiratory Diseases
关键词 结核 结核 抗多种药物性 肺切除术 Tuberculosis, pulmonary Tuberculosis, multidrug-resistant Pneumonectomy
  • 相关文献

参考文献9

二级参考文献33

  • 1唐神结,肖和平.耐多药结核病的综合治疗[J].中华结核和呼吸杂志,2003,26(11):715-718. 被引量:64
  • 2Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs-worldwide, 2000-2004. MMWR Morb Mortal Wkly Rep, 2006,55:301-305.
  • 3Gandhi NR, Moll A, Sturm AW, et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet, 2006,368 : 1575-1580.
  • 4Extensively drug-resistant tuberculosis ( XDR-TB ) : recommendations for prevention and control. Wkly Epidemiol Rec, 2006, 81:430-432.
  • 5Centers for Disease Control and Prevention (CDC). Extensively drug-resistant tuberculosis-United States, 1993-2006. MMWR Morb Mortal Wldy Rep, 2007,56:250-253.
  • 6Masjedi MR, Fta-nia-P, Soroech S, et al. Extensively drugresistant tuberculosis: 2 years of surveillance in Iran. Clin Infect Dis, 2006,43:841-847.
  • 7Migliori GB, Ortmann J, Girardi E, et al. Extensively drugresistant tuberculosis, Italy and Germany. Emerg Infect Dis, 2007,13:780-782.
  • 8Samper S, Martin C. Spread of extensively drug-resistant tuberculosis. Emerg Infect Dis, 2007,13:647-648.
  • 9Dukes Hamilton C, Sterling TR, Blumberg HM, et al. Extensively Drug-resistant tuberculosis: Are we learning from history of repeating it? Clin Infect Dis, 2007,45:338-342.
  • 10Kamolratanakul P,Hiransuthikul N,Singhadong N,et al.Cost analysis of different types of tuberculosis patient at tuberculosis centers in Thailand.Southeast Asian J Trop Med Public Health,2002,33:321-330.

共引文献2988

同被引文献206

引证文献22

二级引证文献360

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部